Department of Hepatology & Gastroenterology, Charité - Universitätsmedizin Berlin, Campus Virchow-Klinikum and Campus Charité Mitte, Berlin, Germany.
Hepatol Commun. 2024 Jul 5;8(7). doi: 10.1097/HC9.0000000000000491. eCollection 2024 Jul 1.
The liver is a vital organ that continuously adapts to a wide and dynamic diversity of self-antigens and xenobiotics. This involves the active contribution of immune cells, particularly by the liver-resident macrophages, the Kupffer cells (KCs), which exert a variety of central functions in liver homeostasis and disease. As such, KCs interact with their microenvironment to shape the hepatic cellular landscape, control gut-derived signal integration, and modulate metabolism. On injury, the rapid recruitment of bone marrow monocyte-derived macrophages alters this status quo and, when unrestrained, drastically compromises liver homeostasis, immune surveillance, and tissue organization. Several factors determine the functional roles of liver macrophages in these processes, such as their ontogeny, activation/polarization profile and, importantly, spatial distribution within the liver. Loss of tolerance and adaptability of the hepatic immune environment may result in persistent inflammation, hepatic fibrosis, cirrhosis, and a tumorigenic niche promoting liver cancer. In this review, we aim at providing the most recent breakthroughs in our understanding of liver macrophage biology, particularly their diversity and adaptability in the hepatic spatiotemporal context, as well as on potential therapeutic interventions that may hold the key to tackling remaining clinical challenges of varying etiologies in hepatology.
肝脏是一个重要的器官,它不断适应广泛而动态的自我抗原和外源性物质的多样性。这涉及到免疫细胞的积极贡献,特别是肝脏驻留巨噬细胞——库普弗细胞(KCs),它们在肝脏稳态和疾病中发挥着各种核心功能。因此,KCs 与它们的微环境相互作用,塑造肝脏的细胞景观,控制肠道衍生的信号整合,并调节代谢。在损伤时,骨髓单核细胞衍生的巨噬细胞的快速募集改变了这种现状,并且如果不受限制,会严重破坏肝脏稳态、免疫监视和组织组织。有几个因素决定了肝巨噬细胞在这些过程中的功能作用,例如它们的发生、激活/极化谱,以及在肝脏内的重要空间分布。肝脏免疫环境的耐受性和适应性丧失可能导致持续的炎症、肝纤维化、肝硬化和促进肝癌的肿瘤发生基质。在这篇综述中,我们旨在提供对肝脏巨噬细胞生物学的最新理解的突破,特别是它们在肝脏时空背景下的多样性和适应性,以及可能对解决不同病因的肝脏学中仍然存在的临床挑战具有关键意义的潜在治疗干预措施。
J Hepatol. 2017-3-4
Cell Immunol. 2018-4-6
Front Immunol. 2019-12-3
Results Probl Cell Differ. 2024
Hepatology. 2015-4-22
Front Immunol. 2020
Cell Immunol. 2017-12-20
Pflugers Arch. 2017-4
Nat Rev Drug Discov. 2025-3-18
Front Med (Lausanne). 2025-1-31
Hepatol Commun. 2024-4-1
Nat Immunol. 2024-1
J Hepatol. 2023-12